Skip to content

Omega-3 add-on did not outperform placebo for youth depression

Depression scores improved in both groups, without a statistically significant difference between the supplement and placebo.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Adding the studied fatty acid supplement to standardized psychotherapy did not outperform placebo for young people with major depression. Depression scores improved similarly in both groups, and secondary outcomes showed no significant between-group differences. The result does not establish equivalence, but it provides no evidence of an added benefit under these trial conditions.

Keep in mind

This abstract-based summary concerns a specific formulation added to psychotherapy for youths with major depression. It cannot establish effects of other formulations, use without psychotherapy or outcomes in other populations.

THE NUMBERS, WITH CONTEXT

What researchers found

0.77 points (95% CI -1.39 to 2.93; P = .49)

Depression rating score (CDRS-R): adjusted mean difference

Supplement versus placebo across 36 weeks. Lower scores indicate improvement. The confidence interval includes zero (no difference), so the result does not establish either a benefit or equivalence.

JAMA Netw Open, 2026 · Original source ↓

Blood changes and symptoms

Blood levels of the supplemented fatty acids rose, supporting adherence. This biological change was not accompanied by significant advantages over placebo in depression ratings, response, remission, quality of life or suicidality.

Safety findings

Serious adverse events included suicide attempts. The abstract reports no deaths or permanent disabilities, and none of these events were judged causally related to the study medication.

CHECK THE ORIGINAL

The original publication

ω-3 Fatty Acids in Pediatric Major Depressive Disorder: A Randomized Clinical Trial.

Berger G, Häberling I, Emery S et al.
JAMA Netw Open · 2026

PubMed ID
41481294
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.